https://doi.org/10.1016/j.biomaterials.2019.02.017
G
Gernot Kaber
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
1.6K
Citations
20
h-index
28
i10-index
Gernot Kaber is an academic researcher from Stanford Medicine. The author has contributed to research in topics: Proteoglycans and glycosaminoglycans research & Pancreatic function and diabetes & Glycosylation and Glycoproteins Research. The author has an h-index of 20, co-authored 57 publications.
ORCID: 0000-0002-6184-5192Papers by this author
worksHydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice
2019 · Biomaterials · 107 citations
4-Methylumbelliferyl glucuronide contributes to hyaluronan synthesis inhibition
2019 · Journal of Biological Chemistry · 50 citations
https://doi.org/10.1074/jbc.ra118.006166
Modified High-Molecular-Weight Hyaluronan Promotes Allergen-Specific Immune Tolerance
2016 · American Journal of Respiratory Cell and Molecular Biology · 32 citations
https://doi.org/10.1165/rcmb.2016-0111oc
Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue
2024 · Nature Communications · 11 citations
https://doi.org/10.1038/s41467-024-45012-9
Engineering T cells with a membrane-tethered version of SLP-76 overcomes antigen-low resistance to CAR T cell therapy
2025 · Nature Cancer · 2 citations
https://doi.org/10.1038/s43018-025-01056-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat